Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development)

Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.

設立年

1994

従業員数

28

業種

製薬

企業タイプ

Privately Held

本社

🇺🇸20 Pacific Dr, Quakertown, Pennsylvania 18951, US (+1)